Camilla Gomiero

Camilla has over 10 years of industry experience advising companies on commercial launch strategies, conducting early-stage asset valuations, and leading commercial due diligence as a consultant focused on the life sciences. Camilla has worked with key stakeholders within the industry to identify and communicate the commercial potential for new treatments across multiple therapy areas and stages of development, with recent expertise in orphan drugs and neurosciences. Camilla previously held positions as Engagement Manager and Consultant with Two Labs, IMS Health and ICON. While at IMS, Camilla helped establish IMS Health Capital, an investment banking company.